Literature DB >> 19721109

Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study.

Jonathan Price1, Victoria Cole, Guy M Goodwin.   

Abstract

BACKGROUND: Some people who take selective serotonin reuptake inhibitor (SSRI) antidepressants report that their experience of emotions is 'blunted'. This phenomenon is poorly understood. AIMS: To understand patients' experiences of this phenomenon.
METHOD: Qualitative study, gathering data through individual interviews, a group interview and validation interviews; and searching patient websites for relevant posts.
RESULTS: There was strong evidence that some people taking SSRIs experience significant emotional symptoms that they strongly attribute to their antidepressant. These emotional symptoms can be described within six key themes. A seventh theme represents the impact of these side-effects on everyday life, and an eighth represents participants' reasons for attributing these symptoms to their antidepressant. Most participants felt able to distinguish between emotional side-effects of antidepressants and emotional symptoms of their depression or other illness.
CONCLUSIONS: Emotional side-effects of SSRIs are a robust phenomenon, prominent in some people's thoughts about their medication, having a demonstrable impact on their functioning and playing a role in their decision-making about antidepressant adherence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19721109     DOI: 10.1192/bjp.bp.108.051110

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  79 in total

1.  Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs.

Authors:  Birgit Abler; Georg Grön; Antonie Hartmann; Coraline Metzger; Martin Walter
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

Review 2.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

3.  Antidepressants: misnamed and misrepresented.

Authors:  Joanna Moncrieff
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

4.  'They won't do any harm and might do some good': time to think again on the use of antidepressants?

Authors:  Hugh Middleton; Joanna Moncrieff
Journal:  Br J Gen Pract       Date:  2011-01       Impact factor: 5.386

5.  A Computational Model of Major Depression: the Role of Glutamate Dysfunction on Cingulo-Frontal Network Dynamics.

Authors:  Juan P Ramirez-Mahaluf; Alexander Roxin; Helen S Mayberg; Albert Compte
Journal:  Cereb Cortex       Date:  2017-01-01       Impact factor: 5.357

6.  Investigating dopamine and glucocorticoid systems as underlying mechanisms of anhedonia.

Authors:  Steven J Lamontagne; Sofia I Melendez; Mary C Olmstead
Journal:  Psychopharmacology (Berl)       Date:  2018-08-22       Impact factor: 4.530

7.  Longitudinal evaluation of anhedonia as a mediator of fear of positive evaluation and other depressive symptoms.

Authors:  D Gage Jordan; E Samuel Winer; Taban Salem; Jenna Kilgore
Journal:  Cogn Emot       Date:  2017-03-06

8.  Reduced reward learning predicts outcome in major depressive disorder.

Authors:  Elske Vrieze; Diego A Pizzagalli; Koen Demyttenaere; Titia Hompes; Pascal Sienaert; Peter de Boer; Mark Schmidt; Stephan Claes
Journal:  Biol Psychiatry       Date:  2012-12-08       Impact factor: 13.382

Review 9.  Positive emotion and cardiovascular disease in elderly people.

Authors:  Lina Ma; Yun Li; Ming Feng
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.

Authors:  Ciara McCabe; Zevic Mishor; Philip J Cowen; Catherine J Harmer
Journal:  Biol Psychiatry       Date:  2009-12-24       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.